ABSTRACT
INTRODUCTION
Traditionally, long reverse transcription polymerase chain reaction (RT-PCR) has not allowed the efficient synthesis of the full-length coding region of long mRNAs in one step. The consequence of this has been that to isolate a full-length cDNA, one must piece together smaller cDNAs that together reconstitute the entire mRNA. The danger in this approach is that the various cDNAs might derive from different but related mRNAs or from various splicevariant mRNAs. The reconstructed cDNA would not be an accurate copy of the original mRNA. The cloning of splice-variant mRNAs is even more difficult. It is virtually impossible to prove that reconstituted cDNAs correspond to a novel splice-variant mRNA when the splice products cannot be predicted in advance. Because many splice products can be rare in abundance relative to the full-length mRNA, the analysis is more difficult.
Recently, RT-PCR technology has improved dramatically, and it is now possible to copy the full-length coding regions of even long mRNAs (6 kb) in one step in one tube (5, 9) . Much of the progress has been due to the commercial availability of optimized reversetranscriptases that can reverse-transcribe RNA at the high temperatures necessary to disrupt secondary structure (12) . The addition of a proofreading enzyme to the DNA polymerase mixture during PCR has also greatly increased the efficiency of this reaction by allowing the correction of mismatched nucleotides and subsequent polymerization through such regions of DNA (1) . Combined, the availability of these improved reagents allows for effective long RT-PCR.
Our laboratory is interested in the roles that two particular mRNAs might have in conferring the drug-resistant phenotype to cancer cells: (i) The multidrug resistance ( MDR1 ) mRNA, which encodes P-glycoprotein, an ABC transporter and a drug pump (2); and (ii)the major vault protein ( MVP ) mRNA, which encodes a protein product that is part of a ribonucleoprotein (RNP) complex that is frequently upregulated in many cancer cells (7, 8, 14) . We have developed RT-PCR technology that allows us to copy the full-length coding region of each of these mRNAs in one step in one tube. Most importantly, through the use of long RT-PCR technology, we can be absolutely sure that the splice-variant mRNAs we identify originate from one original mRNA. To our knowledge, this is a novel application of this technology in that we have isolated and characterized splicevariant mRNAs from these genes in a systematic manner that provides an overall picture of the splicing pattern. We have identified the predominant splice products as well as novel splice 224BioTechniques Other laboratories have also identified splice-variant mRNAs, but the methodology used was quite different from ours. Devine et al. screened 1.7 × 10 4 recombinant colonies from a cDNA library to identify splice-variant mRNAs of MDR1 (4) . In a recent report, opioid receptor splice-variant mRNAs were identified by RT-PCR, but only a small portion of each mRNA was examined (6) . Other methodologies that might allow the synthesis of a full-length, double-stranded (ds)cDNA might result in a much higher background of nonspecific DNA amplification because of the use of a nonspecific 5 ′ primer. We believe our methodology offers distinct advantages to previous approaches.
SHORT TECHNICAL REPORTS

MATERIALS AND METHODS
Cell Lines and RNA Isolation
The vincristine-resistant cell line, HL60/VCR, was selected from the drug-sensitive parent cell line, HL60, by growth in increasing concentrations of the drug (10) . The HL60 cell lines were developed by and obtained from Dr. Melvin Center (Kansas State University). The doxorubicin-resistant cell line, U937-30A-50P, was selected from the drug-sensitive parent cell line, U937, by growth in increasing concentrations of the drug (15) . All these cell lines were maintained in RPMI 1640 Media with 10% fetal bovine serum (FBS) and 50 µ g/mL of gentamicin sulfate (all from Life Technologies, Gaithersburg, MD, USA). Cells were harvested in mid-log growth phase for total RNA isolation. Total cell RNA was isolated from 1.0 ×10 7 cells of each cell line using TRI ZOL ® Reagent as described by the manufacturer (Life Technologies).
Primers for Long and Conventional RT-PCR
Our base numbering system for all cDNAs is based upon the GenBank ® accession number, with base 1 being the 5 ′ most base of the 5 ′ untranslated region. For example, the ATG start co - gels, and DNA bands were detected by staining with 0.5 µ g/mL ethidium bromide using standard methods (13) . Gels were dried under vacuum at 80°C for 2 h and exposed to X-Omat X-ray film (Scientific Imaging Systems [Eastman Kodak], New Haven, CT, USA) at -80°C overnight. A successful long RT-PCR is not dependent on the particular kit used. We have also successfully used a TaKaRa Long RT-PCR Kit (PanVera, Madison, WI, USA) to copy the mRNAs described in this report.
Isolation and Characterization of Full-Length and Splice-Variant MDR1mRNAs
Following long RT-PCR, MDR1 DNA bands of interest were extracted from agarose gels using the QIAquick ™ Gel Extraction Kit (Qiagen, Chatsworth, CA, USA) as described by the manufacturer. Double-stranded cDNAs were then subcloned into pCR ® 2.1 (Invitrogen, Carlsbad, CA, USA) and sequenced using the PRISM™Ready Reaction Dye Terminator Cycle Sequencing Kit and a Model 373A DNA Sequencer (both from PE Applied Biosystems, Foster City, CA, USA). The sequences were analyzed using the BESTFIT and MAP programs of the GCG Version 8.1 software package (Genetic Computer Group, Madison, WI, USA).
RESULTS AND DISCUSSION
We have developed a technique that allows us to detect both full-length and splice-variant mRNAs of MDR1 , MVP or any other mRNA of interest. PCR primers are designed to include or reside 5 ′ to the AUG start codon and to include or reside 3 ′ to the stop codon of the mRNA of interest, and stringent RT-PCR conditions are developed. When a total cell RNA population is analyzed, both full-length and splicevariant mRNAs can be observed following gel electrophoresis of dscDNA products. A few splice-variant dscDNAs can be detected by ethidium bromide staining, while rarer products must be detected by 33 P autoradiography. cDNA clones must be sequenced multiple times to ensure that PCR-generated errors are detected and to define the prevalence of different splice-variant mRNAs.
To use long RT-PCR technology to isolate and characterize splice-variant mRNAs, it was necessary that the technique meet two clear technical criteria. First, one must be able to copy the fulllength coding regions of mRNAs of interest in one step in one tube, thus ensuring that the splice products observed originate from one common mRNA. Secondly, and perhaps not as obvious, the reverse transcriptase and PCR conditions must be very stringent; the use of a pure, full-length RNA transcript control must result in the synthesis of only one full-length dscDNA product. If smaller, artifactual dscDNA products were produced as a result of PCR primer mispairing, the smaller DNAs would appear to be splice-variant products when in fact they were not. We have developed stringent long RT-PCR conditions, that when applied with a pure, full-length MDR1mRNA template control, results in the synthesis of only one full-length dscDNA product band ( Figure 1, lane 1) . Therefore, it is clear that our reverse transcriptase conditions allow us to fully denature the entire mRNA and to efficiently copy through all hairpin stems and loops. Smaller, artifactual DNA bands that might be confused as splice-variant mRNAs, are not produced even when autoradiograms are overexposed for days (data not shown). The use of a full-length MDR1cDNA template control also results in the synthesis of only one full-length dsDNA PCR product band (Figure 1, lane 3) . This again demonstrates that PCR conditions are sufficiently stringent, that primer mispairing does not occur and DNA secondary structure does not present a technical problem. Therefore, we can be certain that the application of this technology to the analysis of a total cell RNA population that contains both fulllength MDR1 mRNA as well as smaller splice-variant mRNAs will accurately detect all forms of the mRNA, and that the detected splice-variant mRNAs will not be the result of a technical artifact. is not due to partial or total degradation of the total RNA preparations. A control demonstrates that GAPDHmRNA is detectable at approximately equal levels in all cell lines, thus ensuring that all RNAs are relatively undegraded (Figure 2A) . A more sensitive conventional short product RT-PCR assay further demonstrates that the two parent cell lines negative for detection of fulllength product do indeed contain a very low but detectable level of MDR1 mRNA ( Figure 2B ). In HL60 and U937 parent cells, both a 191-bp MDR1band and a second, artifactual, higher molecular weight band are observed in the same gel lanes. We see artifactual PCR bands only when the MDR1mRNA concentration is very low, and the PCR substrate is limited. In samples with higher MDR1mRNA concentration, these artifactual bands are not observed. The point to be made is that HL60/parent and U937 cells do contain a very low level of MDR1mRNA.
That these two cell lines have very low levels of MDR1mRNA but undetectable full-length mRNA products, is explained by two factors. First, the efficiency of conversion of a full-length, 3854-base or a splice-form, 1873-base mRNA to a dscDNA is much less efficient than that of a smaller 191-bp conventional RT-PCR product. Secondly, the entire MDR1mRNA sequence can be scanned to find optimal conventional RT-PCR primers; whereas, long RT-PCR primers are constrained to include or flank the start AUG and termination codons and, in general, are not as efficient in PCR. One should therefore be cautious in the interpretation of the inability to detect long RT-PCR products; low levels of a mRNA might still be present that are only detectable with a more sensitive conventional RT-PCR assay. In addition, the use of standard quantitative RT-PCR will determine which splice-variant mRNAs are present at levels that are likely to be biologically significant, e.g., at greater than one copy of mRNA per cell (11) .
The methodology described here is generally applicable to the analysis of other mRNAs and is not dependent on the long RT-PCR kit used, although each mRNA may require some adjusting of the long RT-PCR conditions. We have used this technique to copy the full-length coding regions of the MDR1 , MVPand prostate-specific antigen (PSA; data not shown) mRNAs. In all cases, splice-variant mRNAs are observed and will be characterized.
